WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) was the recipient of a significant decrease in short interest during the month of July. As of July 31st, there was short interest totaling 3,000 shares, adecreaseof87.4% from the July 15th total of 23,900 shares. Based on an average daily volume of 53,100 shares, the short-interest ratio is presently 0.1 days. Based on an average daily volume of 53,100 shares, the short-interest ratio is presently 0.1 days.
Wall Street Analyst Weigh In
Separately, UBS Group raised shares of WuXi Biologics (Cayman) to a “buy” rating in a research report on Thursday, August 7th.
Check Out Our Latest Report on WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Stock Down 1.2%
About WuXi Biologics (Cayman)
WuXi Biologics (Cayman) Inc, an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC.
Featured Stories
- Five stocks we like better than WuXi Biologics (Cayman)
- How to Most Effectively Use the MarketBeat Earnings Screener
- How Did Peter Thiel-Backed Crypto Exchange Bullish’s IPO Go?
- 5 Top Rated Dividend Stocks to Consider
- Mercury Systems Up 27%: Financials Send Investors a Clear Signal
- How to Plot Fibonacci Price Inflection Levels
- Deere’s Sell-Off Could Be a Long-Term Buying Chance
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.